Acidum dihydratum 5-sulfosalicylicum Cas: 5965-83-3 Alba crystallina alba ad
| Catalogue Number | XD90230 |
| Product Name | 5-Sulfosalicylicum acidum dihydratum |
| CAS | 5965-83-3 |
| Formulae hypotheticae | C7H10O8S |
| M. Pondus | 254.215 |
| Repono Details | Ambiens |
| Tariff Code harmonized | 29182900 |
Product Specification
| Sulfate | 5.5% max |
| umor | 22% max |
| Aspectus | Alba ut off-album crystallum |
| Totalis acidum | 99 - 104% |
| Assay | 99% |
Polycationes explorantur ut portatores ad acida nucleica medicinalia liberanda.Polycationes inertes pharmacologicae conventionaliter sunt cum unica functione tradendi onera therapeutica.Hoc studium synthesin refert polycation auto-immolativae (DSS-BEN) innixa in polyamine medicamento analogo N(1),N(11)-bisethylnorsperminei (BENSpm).Polycatio designata est ad functionem dualiter ut tabellarius genee partus et nisi scopuli dysregulati polyamine metabolismi in cancro.Coniunctio NMR et HPL utentes, confirmamus polycationem auto-immolativam degradationem intracellularem in medicamento parentis BENSpm subire.BENSpm dimissi gradus cellulares spermidine et spermine depopulantur et enzymes spermidine catabolico polyamine/spermidine N(1)-acetyltransferase (SSAT) et spermina oxydatis (SMO).Polycationes perstringuntur polyplexes cum DNA formant et transfectio efficiens faciliorem reddit.Inter has facultates BENSpm sentiendi cellas cancer ad TNFα-apoptos inductas est, ostendimus DSS-BEN cellam occisionis activitatem TNFα gene therapiae augere.Inventiones nuntiatae DSS-BEN convalidant sicut systema traditionis dualis functionis quae gene therapeutica liberare potest et exitum generum therapiae emendare propter degradationem intracellularem de DSS-BEN ad BENSpm et subsequentem effectum commodi BENSpm in polyamine dysregulatis. metabolismi in cancro.
